Showing 12 of 12 recruiting trials for “neuromyelitis-optica-spectrum-disorder”
Efficacy and Safety of Transcranial Temporal Interference Stimulation (tTIS) for Neuropathic Pain in Neuromyelitis Optica Spectrum Disorder (NMOSD)
a Chronobiological Treatment Combining Evening Melatonin and Morning Light Therapy in Idiopathic Hypersomnia: a Prospective, Double Bind, Randomized, Placebo-controlled -Trial
A Microdose Trial Investigating Binding of [68Ga]Ga-DOTA-CYS-ATH001 in Healthy Subjects and Different Patient Groups.
👨⚕️ Johan Vessby, Section of Gastroenterology/Hepatology SE-751 85 Uppsala, Sweden📍 3 sites📅 Started Aug 2024View details ↗
RecruitingNCT05891379 ↗
Inebilizumab in Acute Neuromyelitis Optica Spectrum Disorders
RecruitingNCT07434908 ↗
Heparin-binding Protein and Lungedema in ICU Patients.
RecruitingNCT06252493 ↗
Value of PET/MR Enterography in the Assessment of Crohn's Disease Using a Collagen-binding Radiotracer.
👨⚕️ Onofrio Catalano, MD, Ph.D, Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School📍 1 site📅 Started Dec 2023View details ↗
4 Courses vs 2 Courses of Pembrolizumab Combined With Carboplatin and Albumin-binding Paclitaxel of Neoadjuvant Therapy in HNSCC
Fluorine-18-AlphaVBeta6-Binding Peptide Positron Emission Tomography in Metastatic Non-Small Cell Lung Cancer
👨⚕️ Julie L. Sutcliffe, PhD, The Regents of the University of California (Davis)📍 1 site📅 Started Sep 2022View details ↗
RecruitingNCT05004493 ↗
Biorepository and Registry for Plasma Exchange Patients
RecruitingNCT04998227 ↗
Latent TGF-β-binding Proteins Affect the Fibrotic Process in Renal Impairment and Cardiac Dysfunction
RecruitingNCT04106830 ↗
Clinical and Imaging Cohort of Neuroinflammation Diseases in China (CLUE)
RecruitingNCT02253251 ↗
Clinical Validation of the Role of microRNA Binding Site Mutations in Cancer Risk, Prevention and Treatment
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →